FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2165836659> ?p ?o ?g. }

• W2165836659 endingPage "937" @default.
• W2165836659 startingPage "928" @default.
• W2165836659 abstract "ABT-869 [<i>N</i>-(4-(3-amino-1<i>H</i>-indazol-4-yl)phenyl)-<i>N</i>′-(2-fluoro-5-methylphenyl)urea] is a novel multitargeted inhibitor of the vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) receptor tyrosine kinase family members. ABT-869 demonstrates tumor growth inhibition in multiple preclinical animal models and in early clinical trials. VEGF receptor inhibition is also associated with reversible hypertension that may limit its benefit clinically. To evaluate optimal therapeutic approaches to prevent hypertension with VEGF receptor inhibition, we characterized the dose-dependent effects of seven antihypertensive agents from three mechanistic classes [angiotensin-converting enzyme inhibitors (ACEis), angiotensin receptor blockers (ARBs), calcium channel blockers (CCBs)] on hypertension induced by ABT-869 in conscious telemetry rats. We report that ABT-869-induced hypertension can be prevented and reversed with subtherapeutic or therapeutic doses of antihypertensive drugs with a general rank order of ACEi > ARB > CCB. In SCID mice, the ACE inhibitor, enalapril (C₂₀H₂₈N₂O₅·C₄H₄O₄) at 30 mg/kg, prevented hypertension, with no attenuation of the antitumor efficacy of ABT-869. These studies demonstrate that the adverse cardiovascular effects of the VEGF/PDGF receptor tyrosine kinase inhibitor, ABT-869, are readily controlled by conventional antihypertensive therapy without affecting antitumor efficacy." @default.
• W2165836659 created "2016-06-24" @default.
• W2165836659 creator A5021063321 @default.
• W2165836659 creator A5024979827 @default.
• W2165836659 creator A5033898620 @default.
• W2165836659 creator A5038177916 @default.
• W2165836659 creator A5039852503 @default.
• W2165836659 creator A5059164731 @default.
• W2165836659 creator A5059293173 @default.
• W2165836659 creator A5067700779 @default.
• W2165836659 creator A5069934067 @default.
• W2165836659 creator A5072528914 @default.
• W2165836659 creator A5076558706 @default.
• W2165836659 creator A5089429827 @default.
• W2165836659 date "2009-03-02" @default.
• W2165836659 modified "2023-09-27" @default.
• W2165836659 title "Effect of the Multitargeted Receptor Tyrosine Kinase Inhibitor, ABT-869 [<i>N</i>-(4-(3-Amino-1<i>H</i>-indazol-4-yl)phenyl)-<i>N</i>′-(2-fluoro-5-methylphenyl)urea], on Blood Pressure in Conscious Rats and Mice: Reversal with Antihypertensive Agents and Effect on Tumor Growth Inhibition" @default.
• W2165836659 cites W1557061959 @default.
• W2165836659 cites W1639582946 @default.
• W2165836659 cites W1969328947 @default.
• W2165836659 cites W1983143756 @default.
• W2165836659 cites W1998432634 @default.
• W2165836659 cites W2010898909 @default.
• W2165836659 cites W2023696143 @default.
• W2165836659 cites W2031498310 @default.
• W2165836659 cites W2036735258 @default.
• W2165836659 cites W2042676899 @default.
• W2165836659 cites W2043850275 @default.
• W2165836659 cites W2075340577 @default.
• W2165836659 cites W2094825563 @default.
• W2165836659 cites W2095189461 @default.
• W2165836659 cites W2098993893 @default.
• W2165836659 cites W2113788015 @default.
• W2165836659 cites W2125212831 @default.
• W2165836659 cites W2143737148 @default.
• W2165836659 cites W2145221672 @default.
• W2165836659 cites W2155127143 @default.
• W2165836659 cites W2158118791 @default.
• W2165836659 cites W2158965678 @default.
• W2165836659 cites W2169476720 @default.
• W2165836659 cites W4245194102 @default.
• W2165836659 doi "https://doi.org/10.1124/jpet.108.144816" @default.
• W2165836659 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19255283" @default.
• W2165836659 hasPublicationYear "2009" @default.
• W2165836659 type Work @default.
• W2165836659 sameAs 2165836659 @default.
• W2165836659 citedByCount "18" @default.
• W2165836659 countsByYear W21658366592012 @default.
• W2165836659 countsByYear W21658366592013 @default.
• W2165836659 countsByYear W21658366592014 @default.
• W2165836659 countsByYear W21658366592015 @default.
• W2165836659 countsByYear W21658366592016 @default.
• W2165836659 countsByYear W21658366592019 @default.
• W2165836659 countsByYear W21658366592020 @default.
• W2165836659 crossrefType "journal-article" @default.
• W2165836659 hasAuthorship W2165836659A5021063321 @default.
• W2165836659 hasAuthorship W2165836659A5024979827 @default.
• W2165836659 hasAuthorship W2165836659A5033898620 @default.
• W2165836659 hasAuthorship W2165836659A5038177916 @default.
• W2165836659 hasAuthorship W2165836659A5039852503 @default.
• W2165836659 hasAuthorship W2165836659A5059164731 @default.
• W2165836659 hasAuthorship W2165836659A5059293173 @default.
• W2165836659 hasAuthorship W2165836659A5067700779 @default.
• W2165836659 hasAuthorship W2165836659A5069934067 @default.
• W2165836659 hasAuthorship W2165836659A5072528914 @default.
• W2165836659 hasAuthorship W2165836659A5076558706 @default.
• W2165836659 hasAuthorship W2165836659A5089429827 @default.
• W2165836659 hasConcept C126322002 @default.
• W2165836659 hasConcept C134018914 @default.
• W2165836659 hasConcept C170493617 @default.
• W2165836659 hasConcept C180361614 @default.
• W2165836659 hasConcept C185592680 @default.
• W2165836659 hasConcept C27016395 @default.
• W2165836659 hasConcept C2775940317 @default.
• W2165836659 hasConcept C2775960820 @default.
• W2165836659 hasConcept C42362537 @default.
• W2165836659 hasConcept C71924100 @default.
• W2165836659 hasConcept C84393581 @default.
• W2165836659 hasConcept C98274493 @default.
• W2165836659 hasConceptScore W2165836659C126322002 @default.
• W2165836659 hasConceptScore W2165836659C134018914 @default.
• W2165836659 hasConceptScore W2165836659C170493617 @default.
• W2165836659 hasConceptScore W2165836659C180361614 @default.
• W2165836659 hasConceptScore W2165836659C185592680 @default.
• W2165836659 hasConceptScore W2165836659C27016395 @default.
• W2165836659 hasConceptScore W2165836659C2775940317 @default.
• W2165836659 hasConceptScore W2165836659C2775960820 @default.
• W2165836659 hasConceptScore W2165836659C42362537 @default.
• W2165836659 hasConceptScore W2165836659C71924100 @default.
• W2165836659 hasConceptScore W2165836659C84393581 @default.
• W2165836659 hasConceptScore W2165836659C98274493 @default.
• W2165836659 hasIssue "3" @default.
• W2165836659 hasLocation W21658366591 @default.
• W2165836659 hasLocation W21658366592 @default.
• W2165836659 hasOpenAccess W2165836659 @default.
• W2165836659 hasPrimaryLocation W21658366591 @default.
• W2165836659 hasRelatedWork W1996846474 @default.
• W2165836659 hasRelatedWork W2009148223 @default.

• next